The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.
The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.
“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.
Decriminalization of psychedelics and medical treatment are opposite ends of the spectrum.
Not really.
A drug war that criminalized medicine that Dr’s where researching and that people were enjoying for both personal exploration and recreation is the opposite end of the spectrum.